2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023

BACKGROUND: On September 1, 2022, the Advisory Committee on Immunization Practices recommended a bivalent mRNA COVID-19 booster dose for persons who had completed at least a primary COVID-19 vaccination series ≥2 months earlier. Early data showed high effectiveness of a bivalent booster in preventin...

Descripción completa

Detalles Bibliográficos
Autores principales: DeCuir, Jennifer, Zhu, Yuwei, Gaglani, Manjusha, Ginde, Adit A, Mohr, Nicholas, Gibbs, Kevin, Hager, David, Frosch, Anne, Mohamed, Amira, Johnson, Nicholas, Steingrub, Jay S, Peltan, Ithan, Martin, Emily T, Bender, William, Wilson, Jennifer, Qadir, Nida, Mallow, Christopher, Kwon, Jennie H, Exline, Matthew, Lauring, Adam S, Columbus, Cristie, Vaughn, Ivana, Safdar, Basmah, Chappell, James, Baughman, Adrienne, Womack, Kelsey N, Swan, Sydney A, McMorrow, Meredith L, Self, Wesley, Surie, Diya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677158/
http://dx.doi.org/10.1093/ofid/ofad500.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677158/
http://dx.doi.org/10.1093/ofid/ofad500.153

Ejemplares similares